ASSA14-12-14 Long-Term Outcomes of Coronary Stenting in Women versus Men: Results from A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularisation

    loading  Checking for direct PDF access through Ovid



Although procedural success rates are similar by sex, it remains unclear whether long-term outcomes exist between the sexes.


Data on 1900 Chinese patients from a registry evaluating safety and effectiveness of everolimus drug eluting stent for coronary revascularisation (SEEDS) were analysed to compare long-term outcomes by sex.


Female patients (n = 492) were older (63.27 ± 8.38 vs 58.38 ± 9.55, p < 0.05), had more diabetes (31.1% vs 26.4%, p < 0.05) and hypertentions (71.5% vs 61.7%, p < 0.05) than male patients (n = 1408). At one-year follow-up, there was less target vessel failure in female patients than male patients (4.67% vs 6.39%, p < 0.05). There was a trend that rate of cardiac death (0.41% vs 0.50%, p > 0.05), myocardial infarction (3.25% vs 3.48%, p > 0.05), stent thrombosis (0.41% vs 0.64%, p > 0.05) and bleeding (1.22% vs 1.49%, p > 0.05) was lower in female patients.


Women undergoing everolimus drug eluting stent implantation have a slightly higher risk than men, but have better long-term survival, especially for rate of target vessel failure.

Related Topics

    loading  Loading Related Articles